Motive Health
Scottsdale, US · Founded 2013 · Delaware corporation
Motive offers an FDA-cleared neuromuscular electrical stimulation (NMES) therapy that strengthens stabilizing muscles in the lower back and knees to relieve pain and improve mobility without pills, injections, or surgery. The consumer device pairs with the MyMotive app on iOS and Android to control customized therapy sessions.
Founders & leadership
JT
Jeffrey T. ZywickiExecutive
RM
Robert MoroccoExecutive
AB
Alexander B. SuhNamed on SEC filing
EF
Edwin F. SheetzNamed on SEC filing
Board
RA
Rhonda AndersonBoard director
CM
Christopher MartinBoard director
WH
William HannaBoard director
KL
Kelley LipmanBoard director
SH
Struan H. ColemanBoard director
DR
D. Ronald YagodaBoard director
EF
Edwin F. ScheetzBoard director
Reported raises · per SEC filings
Form D private placements$49.5M disclosed across 10 rounds · 2013–2023
▶$15MraisedFeb 2026 · 9 investors · OtherRule 506(b)
▶$15MraisedFeb 2026 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rhonda AndersonDirector
- Christopher MartinDirector
- Jeffrey T. ZywickiExecutive Officer
- William HannaDirector
- Kelley LipmanDirector
- Struan H. ColemanDirector
- Robert MoroccoExecutive Officer, Director
- D. Ronald YagodaDirector
- Edwin F. ScheetzDirector
- Offering amount
- $15.1M
- Amount sold
- $15M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.6MraisedJan 2023 · 3 investors · OtherRule 506(b)
▶$2.6MraisedJan 2023 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- William HannaDirector
- Struan H. ColemanDirector
- Rhonda AndersonDirector
- Edwin F. ScheetzDirector
- D. Ronald YagodaExecutive Officer, Director
- Christopher MartinDirector
- Jeffrey T. ZywickiExecutive Officer
- Robert MoroccoExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $2.6M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.9MraisedNov 2021 · 8 investors · OtherRule 506(b)
▶$3.9MraisedNov 2021 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- D. Ronald YagodaExecutive Officer, Director
- Jeffrey T. ZywickiExecutive Officer
- William HannaDirector
- Robert MoroccoExecutive Officer, Director
- Christopher MartinDirector
- Edwin F. ScheetzDirector
- Rhonda AndersonDirector
- Struan H. ColemanDirector
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedApr 2021 · 16 investors · OtherRule 506(b)
▶$1.8MraisedApr 2021 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Edwin F. ScheetzDirector
- Jeffrey T. ZywickiExecutive Officer
- Struan H. ColemanDirector
- William HannaDirector
- Robert MoroccoExecutive Officer, Director
- Rhonda AndersonDirector
- D. Ronald YagodaExecutive Officer, Director
- Christopher MartinDirector
- Offering amount
- $2.5M
- Amount sold
- $1.8M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedFeb 2020 · 2 investors · OtherRule 506(b)
▶$2.1MraisedFeb 2020 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey T. ZywickiExecutive Officer
- Edwin F. ScheetzDirector
- Rhonda AndersonDirector
- William HannaDirector
- Struan H. ColemanDirector
- Christopher MartinDirector
- D. Ronald YagodaExecutive Officer, Director
- Robert MoroccoExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $2.1M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJun 2019 · 3 investors · OtherRule 506(b)
▶$4MraisedJun 2019 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert MoroccoExecutive Officer, Director
- D. Ronald YagodaExecutive Officer, Director
- Struan H. ColemanDirector
- Rhonda AndersonDirector
- Christopher MartinDirector
- Edwin F. ScheetzDirector
- Jeffrey T. ZywickiExecutive Officer
- William HannaDirector
- Offering amount
- $6M
- Amount sold
- $4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedOct 2018 · 2 investors · OtherRule 506(b)
▶$3MraisedOct 2018 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- William HannaDirector
- Struan H. ColemanDirector
- Jeffrey T. ZywickiExecutive Officer
- Edwin F. ScheetzDirector
- Robert MoroccoExecutive Officer, Director
- D. Ronald YagodaExecutive Officer, Director
- Christopher MartinDirector
- Rhonda AndersonDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedJun 2016 · 23 investors · OtherRule 506(b)
▶$5.6MraisedJun 2016 · 23 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert MoroccoExecutive Officer, Director
- Edwin F. ScheetzDirector
- D. Ronald YagodaExecutive Officer, Director
- William HannaDirector
- Christopher MartinDirector
- Struan H. ColemanDirector
- Jeff ZywickiExecutive Officer
- Offering amount
- $13M
- Amount sold
- $5.6M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Motive Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Motive Health do?
- Motive offers an FDA-cleared neuromuscular electrical stimulation (NMES) therapy that strengthens stabilizing muscles in the lower back and knees to relieve pain and improve mobility without pills, injections, or surgery. The consumer device pairs with the MyMotive app on iOS and Android to control customized therapy sessions.
- How much funding has Motive Health raised?
- Motive Health has disclosed $49.5M raised across 10 rounds.
- Where is Motive Health headquartered?
- Motive Health is headquartered in Scottsdale, US.